European Archives - Page 546 of 1614 - European Medical Journal

The Digital Dermatologist: AI, Telehealth, and Breakthroughs in Skin Care

In this episode of the EMJ Podcast, Jonathan Sackier sits down with Faranak Kamangar…

Automated Insulin Delivery Improves Glycaemic Control in Type 2 Diabetes

Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.

Early Surgery for Childhood Sleep-Disordered Breathing Reduces Healthcare Visits

Adenotonsillectomy significantly reduces healthcare encounters and prescriptions in children with mild sleep-disordered breathing.

Supporting Patients to Improve Mental Health After Liver Transplant Surgery

The findings demonstrated a clear reduction in psychological distress and sleep disturbances among patients who received targeted nursing care.

Researchers Identify the Key Genetic Driver of Lewy Body Disease Pathology

A new study reveals that APOE ε4 drives Lewy body severity, reshaping LBD genetic understanding.

Rheumatoid Arthritis Drug Linked to Lower Risk of Cervical Spine Damage

A decade-long study has found that each year of infliximab use is linked to an 11% lower risk of cervical spine deformity in RA patients, potentially extending the known benefits of the drug beyond peripheral joints.

Jonathan Sackier, hema now highlights

Hema Now: Episode 13: Hema Now Highlights

Take look back at Jonathan Sackier’s highlights from the Hema Now podcast so far, exploring CAR-T therapies, bispecific antibodies and more.

Lung Cancer Screening Adherence Declines, Reducing Detection Rates

A multicentre cohort study found that adherence to annual lung cancer screening declines over time, with lower adherence linked to reduced lung cancer detection rates.

Comorbidities and COVID-19 Mortality in Cancer Patients

A recent study has revealed a significant disparity in COVID-19 mortality rates between Non-Hispanic Black and Non-Hispanic White cancer patients….

Long-Acting Injectable HIV Therapy Shows Early Promise in Human Trials

A first-in-human study evaluating a novel long-acting injectable antiretroviral therapy has provided promising early results on its safety and pharmacokinetics.